CCNP 44th Virtual Annual Meeting
October 27, 2022
Keynote Speaker: Dr. Adrian Owen
The Brain and Mind Institute, Western University
Expert in the lasting impact of COVID-19 on the brain
SAVE THE DATE!
Dear Colleagues,
This is a Call for Abstracts for the 44th Canadian College of Neuropsychopharmacology 2022 meeting to be held virtually on October 27th, 2022.
All accepted abstracts will be published in the Journal of Psychiatry & Neuroscience. Six selected abstracts will be chosen for oral presentations by graduate students (3) and postdoctoral fellows (3) at the meeting’s ‘Next Generation Symposium’. This year the ‘Next Generation’ speakers will receive a $500 honorarium (drawn from our Dewhurst Travel Awards fund).
Abstract submissions should include: (1) Title, (2) List of authors with affiliations, (3) Abstract body (maximum 300 words) separated into: Introduction, Methods, Results and Conclusions, (4) Three sentences (maximum 75 words) stating the significance of the research.
The CCNP is committed to fostering a diverse and inclusive culture, and we encourage individuals from equity seeking groups to submit an abstract, including but not limited to those that are women, persons of colour, Indigenous, members of the LGBTQ2S+ community, neurodiverse, persons with a disability, and others who reflect the diversity of Canadian society.
Junior CCNP members in good standing will be eligible for the awards.
Abstracts and registration are now accepted online.
The deadline for abstract submissions is August 15, 2022.
Aims and Objectives of the College
The principal function of the Canadian College of Neuropsychopharmacology (CCNP) is to further research and education in neuropsychopharmacology and related fields. To achieve this function, the CCNP values open communication between membership and leadership related to governance of the CCNP, and encourages its members to support integrity, collegiality, and ethics in research. The CCNP is committed to maintaining a level of excellence in the conduct of science, supporting discovery and scientific dialogue within an environment that encourages the free expression and exchange of scientific and educational ideas. The CCNP has a tradition of providing a forum for exchange of scientific information between clinical and basic scientists, which is critical for the advancement and translation of scientific discovery in neuropsychopharmacology.Mission
The aim of the College shall be:
a) to provide a forum for clinical and basic science researchers to discuss and exchange ideas and experience in neuropsychopharmacology and to promote the development of this science nationally and internationally.
b) to be a liaison body to educational institutions, public, industry and government organizations as well as other related scientific bodies in order to promote quality of research and treatment in this field.
Journal of Psychiatry & Neuroscience
- The Journal of Psychiatry & Neuroscience has an impact factor of 6.19 (2020 ISI data) and is ranked at #25 out of 156 Psychiatry journals and #51 out of 273 Neuroscience journals, making it the highest ranking open access journal in biological psychiatry. .
- Original research and reviews in basic and clinical science.
- As an open access journal our page charges remain very reasonable with no charge for figures and we are now publishing online only for rapid publication of accepted papers. CCNP members are encouraged to consider JPN for submitting their research (https://jpn.ca).
Revue de psychiatrie & de neuroscience
- Le facteur d'impact de la Revue de psychiatrie et de neuroscience atteint 6,19 (données 2020 de l'ISI), ce qui en fait le journal à accès libre le mieux coté aussi bien dans la catégorie psychiatrie que dans la catégorie neurosciences.
- Recherche originale et analyses critiques en sciences
fondamentales et cliniques. - Les articles publiés dans ce journal sont accessibles gratuitement au http://jpn.ca/ et via PubMed Central.